Literature DB >> 22873184

Reducing stigma through education to enhance Medication-Assisted Recovery.

Joycelyn Sue Woods1, Herman Joseph.   

Abstract

The National Alliance for Medication Assisted Recovery has started projects to address the stigma that impacts medication-assisted treatment. The Certified Medication Assisted Treatment Advocate Program trains patients and professionals for advocacy in seminars and conferences. The MARS Project educates (Einstein, Bronx, New York) buprenorphine and methadone patients to dispel stigma and achieve better treatment outcomes. Beyond MARS trains patients nationwide to replicate the MARS Project. Stop Stigma Now will create a national public relations campaign to overcome ignorance and stigma. These projects have the potential to end stigma and elevate medication-assisted treatment to its rightful place as the gold standard of treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873184     DOI: 10.1080/10550887.2012.694599

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  6 in total

1.  Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).

Authors:  Laramie R Smith; Maria Luisa Mittal; Karla Wagner; Michael M Copenhaver; Chinazo O Cunningham; Valerie A Earnshaw
Journal:  Addiction       Date:  2019-11-27       Impact factor: 6.526

2.  Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.

Authors:  Kamilla L Venner; Dennis M Donovan; Aimee N C Campbell; Dennis C Wendt; Traci Rieckmann; Sandra M Radin; Sandra L Momper; Carmen L Rosa
Journal:  Addict Behav       Date:  2018-05-23       Impact factor: 3.913

Review 3.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

4.  Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.

Authors:  Noa Krawczyk; Sachini Bandara; Sydney Merritt; Hridika Shah; Alexandra Duncan; Brendan McEntee; Maria Schiff; N Jia Ahmad; Sara Whaley; Amanda Latimore; Brendan Saloner
Journal:  Addict Sci Clin Pract       Date:  2022-06-02

5.  Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.

Authors:  Traci R Rieckmann; Amanda J Abraham; Anne E Kovas; Bentson H McFarland; Paul M Roman
Journal:  Addict Behav       Date:  2014-02-07       Impact factor: 3.913

Review 6.  Correlates of methamphetamine use severity among patients receiving methadone maintenance treatment for opioid use disorder in Vietnam.

Authors:  Le Minh Giang; Michael J Li; Chukwuemeka N Okafor; Nguyen Bich Diep; Steven J Shoptaw
Journal:  J Subst Abuse Treat       Date:  2021-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.